Drug Shortage Report for 20% PROSOL
| Report ID | 146109 |
| Drug Identification Number | 02141450 |
| Brand name | 20% PROSOL |
| Common or Proper name | Amino Acid Injection 20% w/v |
| Company Name | BAXTER CORPORATION |
| Market Status | MARKETED |
| Active Ingredient(s) | VALINE TYROSINE L-ASPARTIC ACID SERINE GLUTAMIC ACID PROLINE ARGININE GLYCINE ALANINE TRYPTOPHAN DL-METHIONINE THREONINE PHENYLALANINE LEUCINE ISOLEUCINE HISTIDINE LYSINE |
| Strength(s) | 1.44G 0.05G 0.6G 1.02G 1.02G 1.34G 1.96G 2.06G 2.76G 0.32G 0.76G 0.98G 1G 1.08G 1.08G 1.18G 1.35G |
| Dosage form(s) | LIQUID |
| Route of administration | INTRAVENOUS INTRAVENOUS |
| Packaging size | 2000mL (JB6186) |
| ATC code | B05BA |
| ATC description | I.V. SOLUTIONS |
| Reason for shortage | Demand increase for the drug. |
| Anticipated start date | |
| Actual start date | 2021-09-23 |
| Estimated end date | 2021-10-01 |
| Actual end date | 2021-10-01 |
| Shortage status | Resolved |
| Updated date | 2021-10-02 |
| Company comments | Baxter is experiencing supply constraints due to the shortage of Travasol 10% 3000mL (DIN 00872296). As a result this product has been placed on allocation at 100% of historical usage. |
| Health Canada comments | |
| Tier 3 Status | No |
| Contact Address | 7125 MISSISSAUGA ROAD MISSISSAUGA, ONTARIO CANADA L5N 0C2 |
| Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v6 | 2021-10-02 | English | Compare |
| v5 | 2021-10-01 | French | Compare |
| v4 | 2021-10-01 | English | Compare |
| v3 | 2021-09-24 | English | Compare |
| v2 | 2021-09-23 | French | Compare |
| v1 | 2021-09-23 | English | Compare |
Showing 1 to 6 of 6